Goldman Sachs Group Inc Morphic Holding, Inc. Transaction History

Goldman Sachs Group Inc

  • $580 Billion
  • Q2 2024

A detailed history of Goldman Sachs Group Inc transactions in Morphic Holding, Inc. stock. As of the latest transaction made, Goldman Sachs Group Inc holds 633,573 shares of MORF stock, worth $36.1 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
633,573
Previous 543,945 16.48%
Holding current value
$36.1 Million
Previous $19.1 Million 12.74%
% of portfolio
0.0%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024
BUY
$26.12 - $34.07 $2.34 Million - $3.05 Million
89,628 Added 16.48%
633,573 $21.6 Million
Q1 2024

May 15, 2024
SELL
$26.64 - $40.31 $2.43 Million - $3.67 Million
-91,119 Reduced 14.35%
543,945 $19.1 Million
Q4 2023

Feb 13, 2024
BUY
$19.95 - $31.0 $5.94 Million - $9.22 Million
297,567 Added 88.17%
635,064 $18.3 Million
Q3 2023

May 14, 2024
SELL
$21.33 - $59.42 $6.35 Million - $17.7 Million
-297,567 Reduced 46.86%
337,497 $7.73 Million
Q3 2023

Nov 14, 2023
SELL
$21.33 - $59.42 $392,599 - $1.09 Million
-18,406 Reduced 5.17%
337,497 $7.73 Million
Q2 2023

May 14, 2024
BUY
$34.33 - $62.11 $4.23 Million - $7.66 Million
123,314 Added 53.02%
355,903 $20.4 Million
Q2 2023

Aug 14, 2023
BUY
$34.33 - $62.11 $4.23 Million - $7.66 Million
123,314 Added 53.02%
355,903 $20.4 Million
Q1 2023

May 14, 2024
BUY
$26.01 - $48.69 $978,574 - $1.83 Million
37,623 Added 19.3%
232,589 $8.75 Million
Q1 2023

May 11, 2023
BUY
$26.01 - $48.69 $978,574 - $1.83 Million
37,623 Added 19.3%
232,589 $8.75 Million
Q4 2022

May 14, 2024
BUY
$24.14 - $30.37 $1.84 Million - $2.31 Million
76,129 Added 64.06%
194,966 $5.22 Million
Q4 2022

Feb 13, 2023
BUY
$24.14 - $30.37 $1.84 Million - $2.31 Million
76,129 Added 64.06%
194,966 $5.22 Million
Q3 2022

May 14, 2024
SELL
$22.23 - $33.37 $398,139 - $597,656
-17,910 Reduced 13.1%
118,837 $3.36 Million
Q3 2022

Nov 10, 2022
SELL
$22.23 - $33.37 $398,139 - $597,656
-17,910 Reduced 13.1%
118,837 $3.36 Million
Q2 2022

May 14, 2024
SELL
$19.74 - $43.01 $9.84 Million - $21.4 Million
-498,317 Reduced 78.47%
136,747 $2.97 Million
Q2 2022

Aug 15, 2022
SELL
$19.74 - $43.01 $417,658 - $910,005
-21,158 Reduced 13.4%
136,747 $2.97 Million
Q1 2022

May 16, 2022
SELL
$36.25 - $52.02 $840,130 - $1.21 Million
-23,176 Reduced 12.8%
157,905 $6.34 Million
Q4 2021

Feb 14, 2022
BUY
$43.27 - $65.72 $420,627 - $638,864
9,721 Added 5.67%
181,081 $8.58 Million
Q3 2021

Nov 10, 2021
BUY
$53.61 - $67.5 $9.19 Million - $11.6 Million
171,360 New
171,360 $9.71 Million

Others Institutions Holding MORF

# of Institutions
140
Shares Held
38.7M
Call Options Held
4.2K
Put Options Held
200K
View Full List

About Morphic Holding, Inc.

MORF Quotes by TradingView
  • Ticker MORF
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 38,477,100
  • Market Cap $2.19B
  • Description
  • Morphic Holding, Inc., a biopharmaceutical company, discovers and develops oral small-molecule integrin therapeutics for the treatment of autoimmune, cardiovascular, metabolic diseases, as well as fibrosis and cancer. Its lead product candidates are MORF-057, an a4ß7-specific integrin inhibitor affecting inflammation that is in Phase 1 clinical ...
More about MORF
Track This Portfolio

Track Goldman Sachs Group Inc Portfolio

Follow Goldman Sachs Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email